Cargando…
Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target?
Glycogen synthase kinase 3 (GSK3) has been implicated in neurological disorders; therefore, it is not surprising that there has been an increased focus towards developing therapies directed to this kinase. Unfortunately, these current therapies have not taken into consideration the physiological rol...
Autores principales: | Mondragón-Rodríguez, Siddhartha, Perry, George, Zhu, Xiongwei, Moreira, Paula I., Williams, Sylvain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384908/ https://www.ncbi.nlm.nih.gov/pubmed/22779025 http://dx.doi.org/10.1155/2012/276803 |
Ejemplares similares
-
Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer's Disease Treatment: Rethinking the Current Strategy
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2012) -
Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer's Disease
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2013) -
Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011) -
PROTAC-Induced
Glycogen Synthase Kinase 3β Degradation
as a Potential Therapeutic Strategy for Alzheimer’s Disease
por: Guardigni, Melissa, et al.
Publicado: (2023) -
Glycogen Synthase Kinase 3 Inhibitors in the Next Horizon for Alzheimer's Disease Treatment
por: Martinez, Ana, et al.
Publicado: (2011)